Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry|June 17, 2015
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer's diseaseKonstantin Chegaev, Antonella Federico, Elisabetta Marini, et al.
Molecular Pharmaceutics|June 19, 2018
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological EvaluationsSalvatore Magliocca, Carmen De Caro, Loretta Lazzarato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 14, 2025
FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cellsBenedetta Romano, Maria Cristina Molaro, Fabio Somma, et al.
Cancer Letters|May 4, 2019
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenograftsElena Gazzano, Ilaria Buondonno, Alessandro Marengo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2017
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumorsElena Gazzano, Barbara Rolando, Konstantin Chegaev, et al.
Cells|May 10, 2024
Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-GemcitabineTiago M A Carvalho, Madelaine Magalì Audero, Maria Raffaella Greco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2024
Multiple drug-delivery strategies to enhance the pharmacological and toxicological properties of Mefenamic acidClaudia Cristiano, Robert J Cavanagh, Valentina Cuzzucoli Crucitti, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3Marco L Lolli, Irene M Carnovale, Agnese C Pippione, et al.
Iscience|May 6, 2026
Two birds with one stone: An antibiotic hit blocking Staphylococcus aureus heme uptake with serendipitous hemoglobin left-shifting activitySarah Hijazi, Francesco Marchesani, Marialaura Marchetti, et al.
European Journal of Medicinal Chemistry|June 8, 2023
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammationSimone Gastaldi, Carmine Rocca, Eleonora Gianquinto, et al.
Pageof 11